Status:
COMPLETED
ArticuGrasp Trial: New Flexible Tool vs Standard Grasper for Lung Cancer Node Removal in Keyhole Chest Surgery
Lead Sponsor:
Jianxing He
Conditions:
Non-Small Cell Lung Cancer
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study is testing whether a new, flexible surgical tool-the SurgeoFlex Grasp-makes keyhole chest operations for early-stage lung cancer easier, faster, and safer than the standard rigid tool used ...
Eligibility Criteria
Inclusion
- Eligibility Criteria
- Inclusion Criteria
- Age 18-70 years, any sex
- BMI 18.5-30 kg/m²
- Newly diagnosed non-small-cell lung cancer with pre-operative clinical stage cT1-2N0-1M0
- Scheduled to undergo single-port video-assisted thoracoscopic lobectomy with systematic lymph-node dissection
- Major organ function sufficient for surgery
- Written informed consent provided
- Exclusion Criteria
- Small-cell lung cancer or mixed-type lung cancer
- Tumor invasion of main bronchus, chest wall, diaphragm, or major mediastinal vessels
- Previous ipsilateral thoracic surgery or prior neoadjuvant chemotherapy, radiotherapy, targeted therapy, or immunotherapy
- Severe cardiopulmonary dysfunction (FEV₁ \<50 % predicted or LVEF \<40 %)
- Pregnant or breastfeeding women
- Participation in another interventional clinical trial
Exclusion
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07201077
Start Date
January 1 2025
End Date
March 31 2025
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510120